{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:54:18Z","timestamp":1772895258380,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial Research, South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["142089"],"award-info":[{"award-number":["142089"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"Universityof CapeTown","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["22\/87"],"award-info":[{"award-number":["22\/87"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001338","name":"University of Capetown","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"ICGEB","doi-asserted-by":"publisher","award":["SAWBP\/PHD\/001"],"award-info":[{"award-number":["SAWBP\/PHD\/001"]}],"id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.virol.2025.110666","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T06:30:05Z","timestamp":1755930605000},"page":"110666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of \u03b3-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa"],"prefix":"10.1016","volume":"611","author":[{"given":"Prishanta","family":"Chinna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humaira","family":"Lambarey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-3828","authenticated-orcid":false,"given":"Georgia","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110666_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2334-8-111","article-title":"Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa","volume":"8","author":"Adjei","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2025.110666_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","author":"Al-Aly","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2025.110666_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199157","article-title":"Incidence of epstein-barr virus reactivation is elevated in COVID-19 patients","volume":"334","author":"Bernal","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2025.110666_bib4","series-title":"Kaposi sarcoma\u2013associated herpesvirus-associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment, Seminars in Oncology","first-page":"223","author":"Bhutani","year":"2015"},{"key":"10.1016\/j.virol.2025.110666_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2160","article-title":"Evidence for altered host genetic factors in KSHV infection and KSHV-Related disease development","volume":"31","author":"Blumenthal","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2025.110666_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.795555","article-title":"Kaposi's sarcoma-associated herpesvirus, but not epstein-barr virus, Co-infection associates with coronavirus disease 2019 severity and outcome in South African patients","volume":"12","author":"Blumenthal","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2025.110666_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/infdis\/jiz180","article-title":"The contribution of kaposi's sarcoma\u2013associated herpesvirus to mortality in hospitalized human immunodeficiency virus\u2013infected patients being investigated for tuberculosis in South Africa","volume":"220","author":"Blumenthal","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110666_bib8","unstructured":"Chandran, B., Hutt-Fletcher, L., 2007. Gammaherpesviruses entry and early events during infection. In: Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., editors. Human herpesviruses: Biology, therapy, and immunoprophylaxis.Cambridge: Cambridge University Press; 2007. Chapter 23. PMID: 21348095."},{"key":"10.1016\/j.virol.2025.110666_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s42003-021-02220-z","article-title":"SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus","volume":"4","author":"Chen","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.virol.2025.110666_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02395-21","article-title":"The Anti-COVID-19 drug remdesivir promotes oncogenic herpesvirus reactivation through regulation of intracellular signaling pathways","volume":"66","author":"Chen","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110666_bib11","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1002\/jmv.27994","article-title":"SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era?","volume":"94","author":"Chen","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2025.110666_bib12","article-title":"Positive epstein\u2013barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110666_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-0934(00)00244-5","article-title":"A quantification of human cells using an ERV-3 real time PCR assay","volume":"91","author":"Chin Yuan","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2025.110666_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713066","article-title":"The impact of Co-Infections for human gammaherpesvirus infection and associated pathologies","volume":"24","author":"Chinna","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2025.110666_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2023.1103737","article-title":"Malignancy and viral infections in Sub-Saharan Africa: a review","volume":"3","author":"Diakite","year":"2023","journal-title":"Frontiers in Virology"},{"key":"10.1016\/j.virol.2025.110666_bib16","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/ijc.25235","article-title":"Substantial regional differences in human herpesvirus 8 seroprevalence in sub\u2010Saharan Africa: insights on the origin of the \u201cKaposi's sarcoma belt\u201d","volume":"127","author":"Dollard","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2025.110666_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2440490","article-title":"A KSHV-Targeted small molecule efficiently blocks SARS-CoV-2 infection via inhibiting expression of EGFR and cyclin A2","volume":"14","author":"Dong","year":"2025","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.virol.2025.110666_bib18","article-title":"Lymphomas associated with epstein-barr virus infection in 2020: results from a large, unselected case series in France","author":"Donzel","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.virol.2025.110666_bib19","series-title":"The Role of the Epstein-Barr Virus Lytic Cycle in Tumor Progression: Consequences in Diagnosis and Therapy","article-title":"Symptoms, diagnosis and treatment","author":"Drouet","year":"2019"},{"key":"10.1016\/j.virol.2025.110666_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3324\/haematol.2018.193714","article-title":"Defining the elusive boundaries of chronic active epstein-barr virus infection","volume":"103","author":"Fernandez-Pol","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.virol.2025.110666_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2025.110666_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/QAD.0000000000001567","article-title":"HIV-Associated kaposi sarcoma and related diseases","volume":"31","author":"Gon\u00e7alves","year":"2017","journal-title":"Aids"},{"key":"10.1016\/j.virol.2025.110666_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/embo-reports\/kvf031","article-title":"MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling","volume":"3","author":"Gruffat","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.virol.2025.110666_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/Iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, E pstein\u2013B arr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.virol.2025.110666_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246208","article-title":"Kaposi's sarcoma-associated herpesvirus, the etiological agent of all epidemiological forms of kaposi's sarcoma","volume":"13","author":"Jary","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.virol.2025.110666_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001569","article-title":"Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and epstein-barr virus lytic replication initiators in dually-infected primary effusion lymphoma","volume":"3","author":"Jiang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110666_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1270935","article-title":"Co-infection and co-localization of kaposi sarcoma-associated herpesvirus and epstein-barr virus in HIV-Associated kaposi sarcoma: a case report","volume":"13","author":"Julius","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2025.110666_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","article-title":"Measuring epstein\u2013barr virus (EBV) load: the significance and application for each EBV\u2010associated disease","volume":"18","author":"Kimura","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virol.2025.110666_bib29","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/ijc.32546","article-title":"Mutual detection of Kaposi's sarcoma-associated herpesvirus and epstein-barr virus in blood and saliva of cameroonians with and without kaposi's sarcoma","volume":"145","author":"Labo","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2025.110666_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104986","article-title":"Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-Infected patients","volume":"100","author":"Lambarey","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virol.2025.110666_bib31","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/314691","article-title":"Persistently high epstein-barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection","volume":"179","author":"Maeda","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110666_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1068000","article-title":"Epstein barr virus reactivation during COVID-19 hospitalization significantly increased mortality\/death in SARS-CoV-2(+)\/EBV(+) than SARS-CoV-2(+)\/EBV(-) patients: a comparative meta-analysis","volume":"2023","author":"Manoharan","year":"2023","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.virol.2025.110666_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chom.2017.06.009","article-title":"Persistent KSHV infection increases EBV-associated tumor formation in vivo via enhanced EBV lytic gene expression","volume":"22","author":"McHugh","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2025.110666_bib34","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","article-title":"Human gammaherpesvirus immune evasion strategies","author":"Means","year":"2007"},{"key":"10.1016\/j.virol.2025.110666_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.597","article-title":"COVID-19 associated EBV reactivation and effects of ganciclovir treatment","volume":"10","author":"Meng","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.virol.2025.110666_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","article-title":"Kaposi's sarcoma and its associated herpesvirus","volume":"10","author":"Mesri","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virol.2025.110666_bib37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/jvi.71.1.314-324.1997","article-title":"Selective switch between latency and lytic replication of kaposi's sarcoma herpesvirus and epstein-barr virus in dually infected body cavity lymphoma cells","volume":"71","author":"Miller","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110666_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-021-00252-x","article-title":"SARS-CoV-2 and EBV; the cost of a second mitochondrial \u201cwhammy\u201d","volume":"18","author":"Nunn","year":"2021","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.virol.2025.110666_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","article-title":"EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count","volume":"104","author":"Paolucci","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2025.110666_bib40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: an overview","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"key":"10.1016\/j.virol.2025.110666_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000331","article-title":"Cancer as a prospective sequela of long COVID\u201019","volume":"43","author":"Saini","year":"2021","journal-title":"Bioessays"},{"key":"10.1016\/j.virol.2025.110666_bib42","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/biom11091380","article-title":"Stress-induced epstein-barr virus reactivation","volume":"11","author":"Sausen","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.virol.2025.110666_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High incidence of epstein\u2013barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infectious Diseases Now"},{"key":"10.1016\/j.virol.2025.110666_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00211","article-title":"Epstein\u2013barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.virol.2025.110666_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein\u2013barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2025.110666_bib46","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JCM.37.9.2852-2857.1999","article-title":"Monitoring of epstein-barr virus DNA load in peripheral blood by quantitative competitive PCR","volume":"37","author":"Stevens","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2025.110666_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215534","article-title":"Clinical and therapeutic implications of epstein-barr virus in HIV-related lymphomas","volume":"13","author":"Verdu-Bou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.virol.2025.110666_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399404008440","article-title":"Infectious mononucleosis and epstein-barr virus","volume":"6","author":"Vetsika","year":"2004","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.virol.2025.110666_bib49","series-title":"The Role of HIV Viral Suppression in Improving Individual Health and Reducing Transmission: Policy Brief","year":"2023"},{"key":"10.1016\/j.virol.2025.110666_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of epstein\u2013barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.virol.2025.110666_bib51","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1186\/s12879-021-06638-y","article-title":"Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with epstein-barr virus reactivation","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2025.110666_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12250-019-00114-3","article-title":"Towards better understanding of KSHV life cycle: from transcription and posttranscriptional regulations to pathogenesis","volume":"34","author":"Yan","year":"2019","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virol.2025.110666_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/vim.2022.0200","article-title":"Immunity and immune evasion mechanisms of epstein-barr virus","volume":"36","author":"Yao","year":"2023","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virol.2025.110666_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jinf.2020.11.027","article-title":"Clinical application of epstein-barr virus DNA loads in epstein-barr virus-associated diseases: a cohort study","volume":"82","author":"Yu","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.virol.2025.110666_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19138125","article-title":"The HIV epidemic in South Africa: key findings from 2017 national population-based survey","volume":"19","author":"Zuma","year":"2022","journal-title":"Int J Environ Res Public Health"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:43:01Z","timestamp":1772822581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225002806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S0042682225002806"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110666","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of \u03b3-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110666"}}